We are live on ! Find out more
CFM

Catalyst Funds Management Portfolio holdings

AUM $591M
1-Year Est. Return 71.09%
This Fund
S&P 500
This Quarter Est. Return
+11.2%
1 Year Est. Return
+71.09%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$591M
AUM Growth
+$160M
Cap. Flow
+$155M
Cap. Flow %
26.27%
Top 10 Hldgs %
18.1%
Holding
732
New
402
Increased
110
Reduced
53
Closed
148

Top Buys

Rank Stock Value
1
MDLN
Medline Inc
MDLN
+$11.5M
2
ARM icon
Arm
ARM
+$10.9M
3
AZN icon
AstraZeneca
AZN
+$10M
4
CSCO icon
Cisco
CSCO
+$8.29M
5
ABBV icon
AbbVie
ABBV
+$7.72M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$24.5M
2
NVDA icon
NVIDIA
NVDA
+$16.4M
3
RVMD icon
Revolution Medicines
RVMD
+$15.9M
4
RIO icon
Rio Tinto
RIO
+$11.5M
5
WMT icon
Walmart Inc
WMT
+$9.5M

Sector Composition

Rank Sector Weight
1 Technology 22.62%
2 Industrials 14.98%
3 Healthcare 13.14%
4 Financials 10.95%
5 Materials 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PROK icon
501
ProKidney
PROK
$314M
$85.6K 0.01%
+47,800
New +$101K
IDN icon
502
Intellicheck
IDN
$75.3M
$84.6K 0.01%
+12,100
New +$65.7K
RIG icon
503
Transocean
RIG
$5.87B
$83.5K 0.01%
+12,600
New +$71K
APPS icon
504
Digital Turbine
APPS
$1.03B
$82.7K 0.01%
+28,700
New +$123K
SRI icon
505
Stoneridge
SRI
$209M
$81.8K 0.01%
+16,936
New +$116K
XMAX
506
XMAX Inc
XMAX
$547M
$80.4K 0.01%
+11,100
New +$68.9K
GTM
507
ZoomInfo Technologies
GTM
$861M
$80.1K 0.01%
+13,400
New +$98.5K
ORMP icon
508
Oramed Pharmaceuticals
ORMP
$165M
$79.9K 0.01%
+23,500
New +$79.7K
IVVD icon
509
Invivyd
IVVD
$183M
$78.5K 0.01%
+60,400
New +$111K
ONL
510
Orion Office REIT
ONL
$149M
$77.2K 0.01%
+35,900
New +$83.1K
SITC icon
511
SITE Centers
SITC
$224M
$75.1K 0.01%
13,900
– –
BB icon
512
BlackBerry
BB
$5.25B
$74.1K 0.01%
+22,885
New +$80.9K
LUMN icon
513
Lumen
LUMN
$6.9B
$72.7K 0.01%
+10,459
New +$79.2K
SGMT icon
514
Sagimet Biosciences
SGMT
$435M
$72.6K 0.01%
+13,900
New +$77.5K
DIBS icon
515
1stdibs.com
DIBS
$162M
$72.6K 0.01%
+13,200
New +$73.1K
BTX
516
BlackRock Technology and Private Equity Term Trust
BTX
$984M
$71.9K 0.01%
+10,900
New +$72.1K
JBI icon
517
Janus International
JBI
$726M
$71.6K 0.01%
+13,900
New +$90K
MNKD icon
518
MannKind Corp
MNKD
$1.19B
$71.1K 0.01%
29,035
+1,800
+7% +$8.03K
CCCC icon
519
C4 Therapeutics
CCCC
$414M
$67.7K 0.01%
25,740
-16,760
-39% -$39.5K
TSHA icon
520
Taysha Gene Therapies
TSHA
$1.63B
$67.5K 0.01%
+15,100
New +$70.2K
IMRX icon
521
Immuneering
IMRX
$289M
$67.5K 0.01%
+12,800
New +$65.6K
SES icon
522
SES AI
SES
$218M
$65.1K 0.01%
+67,700
New +$115K
NMRA icon
523
Neumora Therapeutics
NMRA
$285M
$64.9K 0.01%
33,300
+3,700
+13% +$9.59K
MDXH icon
524
MDxHealth
MDXH
$22.4M
$64.5K 0.01%
+28,046
New +$95.2K
LTRX icon
525
Lantronix
LTRX
$246M
$63.4K 0.01%
+12,100
New +$74K
19 20
21
22 23

Similar funds

BBL
Beck Bode LLC Dedham, Massachusetts $591M AUM 37.12% 1-Year Est. Return
BA
Bellwether Advisors Lincoln, Nebraska $590M AUM 35.66% 1-Year Est. Return
DPRC
Deer Park Road Corp Steamboat Springs, Colorado $591M AUM 27.7% 1-Year Est. Return
FL
Fourthstone LLC St Louis, Missouri $590M AUM 29.58% 1-Year Est. Return
MW
Maia Wealth Denver, Colorado $591M AUM 16.31% 1-Year Est. Return
SM
Sunriver Management Greenwich, Connecticut $591M AUM 2.74% 1-Year Est. Return
LBIM
Land & Buildings Investment Management Stamford, Connecticut $591M AUM 10.19% 1-Year Est. Return
MPW
MA Private Wealth San Carlos, California $591M AUM 16.05% 1-Year Est. Return

Catalyst Funds Management's Q1 2026 Portfolio in Review

As of Q1 2026, Catalyst Funds Management held 732 positions worth $591M, up 37% from $431M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Catalyst Funds Management deployed $155M of net new capital in Q1 2026, opening 402 new positions and adding to 110 existing holdings. Its largest new stake was Medline Inc: 259,595 shares worth $11.6M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Broadcom, an estimated $24.5M trimmed.

  • Catalyst Funds Management's largest Q1 2026 buy was Medline Inc: 259,595 shares worth $11.6M.
  • Catalyst Funds Management added most to AstraZeneca in Q1 2026, an estimated $10M increase.
  • Catalyst Funds Management's biggest Q1 2026 reduction was Broadcom, cutting an estimated $24.5M.
  • Catalyst Funds Management fully exited News Corp Class B in Q1 2026, selling an estimated $5.22M.
  • Catalyst Funds Management's ten largest holdings make up 18% of its $591M portfolio in Q1 2026.
  • Catalyst Funds Management opened 402 new positions and closed 148 in Q1 2026.
  • Catalyst Funds Management's portfolio value rose 37% quarter-over-quarter to $591M.

Based on Catalyst Funds Management's 13F filing for Q1 2026, filed 11 May 2026.